Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment.

Nutr J · 2018 · PMC6192340 · PMID 30333016

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

have previously demonstrated that the long-term tracking (over 3 years) of the biomarker (plasma phospholipid n-3 PUFAs) was highly significant [ 22 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.